Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells (original) (raw)
References
Aebi, S., Kurdi-Haidar, B., Gordon, R., Cenni, B., Zheng, H., Fink, D., Christen, R. D., Boland, C. R., Koi, M., Fishel, R. & Howell, S. B. (1996). Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res56: 3087–3090. CASPubMed Google Scholar
Aebi, S., Fink, D., Gordon, R., Kim, H. K., Zheng, H., Fink, J. L. & Howell, S. B. (1997). Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res3: 1763–1767. CASPubMed Google Scholar
Baskaran, R., Chiang, G. G. & Wang, J. Y. J. (1996). Identification of a binding site in c-Abl tyrosine kinase for the C-terminal repeated domain of RNA polymerase II. Mol Cell Biol16: 3361–3369. ArticleCASPubMedPubMed Central Google Scholar
Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B. & Wang, J. Y. J. (1997). Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature387: 516–519. ArticleCASPubMed Google Scholar
Cavigelli, M., Dolfi, F., Claret, F. X. & Karin, M. (1995). Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J14: 5957–5964. ArticleCASPubMedPubMed Central Google Scholar
Chaney, S. G. (1995). The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand. Int J Oncol6: 1291–1305. CASPubMed Google Scholar
Chen, Z., Naito, M., Mashima, T. & Tsuruo, T. (1996). Activation of actin-cleavable interleukin 1-converting enzyme (ICE) family protease CCP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res56: 5224–5229. CASPubMed Google Scholar
Christian, M. C. (1992). The current status of new platinum analogs. Semin Oncol19: 720–733. CASPubMed Google Scholar
Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M. & Davis, R. J. (1994). JNK1: a protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-Jun activation domain. Cell76: 1025–1037. ArticleCASPubMed Google Scholar
Derijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Han, J., Ulevitch, R. J. & Davis, R. J. (1995). Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science267: 682–685. ArticleCASPubMed Google Scholar
Duckett, D. R., Drummond, J. T., Murchie, A. I. H., Readon, J. T., Sancar, A., Lilley, D. M. J. & Modrich, P. (1996). Human MutSα recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc Natl Acad Sci USA93: 6443–6447. ArticleCASPubMedPubMed Central Google Scholar
Eastman, A. (1990). Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells2: 275–280. CASPubMed Google Scholar
Fink, D., Nebel, S., Aebi, S., Zheng, H., Cenni, B., Nehmé, A., Christen, R. D. & Howell, S. B. (1996). The role of DNA mismatch repair in platinum drug resistance. Cancer Res56: 4881–4886. CASPubMed Google Scholar
Fink, D., Zheng, H., Nebel, S., Norris, P. S., Aebi, S., Lin, T-P, Nehmé, A., Christen, R. D., Haas, M., Macleod, C. L. & Howell, S. B. (1997). In vitro and In vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res53: 1841–1845. Google Scholar
Fishel, R. & Wilson, T. (1997). MutS homologs in mammalian cells. Curr Opin Genet Dev7: 105–113. ArticleCASPubMed Google Scholar
Gupta, S., Campbell, D., Derijard, B. & Davis, R. J. (1995). Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science267: 389–393. ArticleCASPubMed Google Scholar
Hawn, M. T., Umar, A., Carethers, J. M., Marra, G., Kunkel, T. A., Boland, C. R. & Koi, M. (1995). Evidence for a connection between the mismatch repair system and the G2cell cycle checkpoint. Cancer Res55: 3721–3725. CASPubMed Google Scholar
Hibi, M., Lin, A., Smeal, T., Minden, A. & Karin, M. (1993). Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev7: 2135–2148. ArticleCASPubMed Google Scholar
Kat, A., Thilly, W. G., Fang, W., Longley, M. J., Li, G. & Modrich, P. (1995). An alkylation–toleration, mutator human cell line is deficient in strand-specific mismatch repair. Proc Natl Acad Sci USA90: 6424–6428. Article Google Scholar
Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R. & Kufe, D. W. (1995). Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature376: 785–788. ArticleCASPubMed Google Scholar
Kharbanda, S., Pandey, P., Jin, S., Inoue, S., Bharti, A., Yan, Z-M, Weicheselbaum, R., Weaver, D. & Kufe, D. (1997). Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature386: 732–735. ArticleCASPubMed Google Scholar
Kipreos, E. T. & Wang, J. Y. J. (1992). Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science256: 382–385. ArticleCASPubMed Google Scholar
Koi, M., Umar, A., Chauhan, D. P., Cherian, S. P., Carethers, J. M., Kunkel, T. A. & Boland, C. R. (1994). Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces_N_-methyl-_N_′-nitro-_N_-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res54: 4308–4312. CASPubMed Google Scholar
Kolodner, R. (1996). Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev10: 1433–1442. ArticleCASPubMed Google Scholar
Liu, Z-G, Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M. & Wang, J. Y. J. (1996a). Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature384: 273–276. ArticleCASPubMed Google Scholar
Liu, Z-G, Hsu, H., Goeddel, D. V. & Karin, M. (1996b). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death. Cell87: 565–576. ArticleCASPubMed Google Scholar
Los, G., Mutsaers, P. H., Ruevekamp, M. & McVie, J. G. (1990). The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat. Cancer Lett51: 109–117. ArticleCASPubMed Google Scholar
Mattioni, T., Jackson, P. K., van Huijsduijnen, OB-H & Picard, D. (1995). Cell cycle arrest by tyrosine kinase Abl involves altered early mitogenic response. Oncogene10: 1325–1333. CASPubMed Google Scholar
Mello, J. A., Acharya, S., Fishel, R. & Essigmann, J. M. (1996). The mismatch-repair protein hMSH2 binds selectivity to DNA adducts of the anticancer drug cisplatin. Chem Biol3: 579–589. ArticleCASPubMed Google Scholar
Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Woodrich, M., Campbell, H., Mayo, J. & Boyd, M. (1991). Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst83: 757–766. ArticleCASPubMed Google Scholar
Nehme, A., Rajasekaran, B., Aebi, S., Fink, D., Nebel, S., Cenni, B., Wang, J. Y. J., Howell, S. B. & Christen, R. D. (1997). Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res57: 3253–3257. CASPubMed Google Scholar
Orth, K., Hung, J., Gazdar, A., Bowcock, A., Mathis, J. M. & Sambrook, J. (1994). Genetic instability in human ovarian cancer cell lines. Proc Natl Acad Sci USA91: 9495–9499. ArticleCASPubMedPubMed Central Google Scholar
Saris, C. P., van de Vaart, P. J. M., Rietbroek, R. C. & Blommaert, F. A. (1996). _In vitro_formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells. Carcinogenesis17: 2763–2769. ArticleCASPubMed Google Scholar
Sawyers, C. L., McLaughlin, J., Goga, A., Havlik, M. & Witte, O. (1994). The nuclear tyrosine kinase c-abl negatively regulates cell growth. Cell77: 121–131. ArticleCASPubMed Google Scholar
Schmidt, W. & Chaney, S. G. (1993). Role of carrier ligand in platinum resistance of human carcinoma cell lines. Cancer Res53: 799–805. CASPubMed Google Scholar
Shafman, T., Khanna, K. K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, M., Zhang, N., Watters, D., Egerton, M., Shiloh, Y., Kharbanda, S., Kufe, D. & Lavin, M. F. (1997). Interaction between ATM protein and c-Abl in response to DNA damage. Nature387: 520–523. ArticleCASPubMed Google Scholar
Skehan, P., Storeng, R., Scudiero, D., Monks, A., Mcmahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S. & Boyd, M. R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst82: 1107–1112. ArticleCASPubMed Google Scholar
Umar, A., Boyer, J. C., Thomas, D. C., Nguyen, D. C., Risinger, J. I., Boyd, J., Ionov, Y., Perucho, M. & Kunkel, T. A. (1994). Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem269: 14367–14370. CASPubMed Google Scholar
Umar, A., Koi, M., Risinger, J. I., Glaab, W., Tindall, K. R., Kolodner, R., Boland, C. R., Barrett, J. C. & Kunkel, T. A. (1997). Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine-resistance and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res57: 3949–4955. CASPubMed Google Scholar
Wang, J. Y. J. (1993). Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr Opin Genet Dev3: 35–43. ArticleCASPubMed Google Scholar
Woynarowski, J. M., Chapman, W. G., Napier, C. & Raymond, E. (1997). Oxaliplatin effects on naked and intracellular DNA. Proc Am Assoc Cancer Res38: 311 Google Scholar
Yuan, Z. M., Huang, Y., Ishiko, T., Kharbanda, S., Weichselbaum, R. & Kufe, D. (1997). Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc Natl Acad Sci USA94: 1437–1440. ArticleCASPubMedPubMed Central Google Scholar